Medindia

X

Nationwide Health Properties, Inc. Reports 2010 First Quarter Results

Friday, May 7, 2010 Corporate News J E 4
Advertisement


NEWPORT BEACH, Calif., May 6 Nationwide Health Properties, Inc. (NYSE: NHP) today announced results of operations for the first quarter ended March 31, 2010. Contemporaneously with this press release, the Company filed its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2010 with the Securities and Exchange Commission.

"We began 2010 with a strong balance sheet and an enviable liquidity position. Leveraging our excellent financial position with improvements in the capital markets and the economy, we acquired during the first quarter seven medical office buildings and made an $80 million loan secured by 26 medical office buildings located in seven states," commented Douglas M. Pasquale, NHP's Chairman and Chief Executive Officer. "Subsequent to quarter end, we have completed an additional $58 million of investments bringing the year to date total to $438 million," Mr. Pasquale added.

FIRST QUARTER 2010 RESULTS OF OPERATIONS

The following table presents selected unaudited financial information for the first quarter ended March 31, 2010 as compared to the same period of 2009:

NON-GAAP FINANCIAL MEASURES

Diluted Funds From Operations ("FFO") and Diluted Funds Available for Distribution ("FAD") are non-GAAP measures that we believe are important to understanding our operations. We believe diluted FFO is an important supplemental measure of operating performance because it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). We believe diluted FAD is an important supplemental measure of operating performance because, like diluted FFO, it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). It also excludes straight-lined rent and other non-cash items that have become more significant for us and our competitors over the last several years. We believe that net income is the most directly comparable GAAP measure to diluted FFO and diluted FAD. Reconciliations between net income and diluted FFO and net income and diluted FAD are included in the accompanying financial data. For guidance, we have also included in the accompanying financial data reconciliations between net income per share and diluted FFO and diluted FAD per share. We have also included adjusted diluted FFO and adjusted diluted FAD amounts which exclude acquisition costs and the recognition of a net gain on re-measurement of equity interest upon acquisition and a gain on debt extinguishment in 2010.

FIRST QUARTER 2010 INVESTMENT ACTIVITY

Pacific Medical Buildings Update

In February of 2010, we acquired the Poway, CA medical office building for $74.0 million including the issuance of 301,599 OP units and a 71% interest in a joint venture which owns a medical office building in Gilbert, AZ for $6.3 million. Additionally, we committed to loan the joint venture $8.8 million of which we have funded $6.8 million.

In March of 2010, we acquired a 65% interest in a joint venture that owns the Mission Viejo, CA medical office building valued at $79.9 million including the assumption of a $48.1 million mortgage loan with a fixed interest rate of 5.5% expiring in 2017 and the issuance of 152,238 OP units; a 69% interest in a joint venture that owns the Orange, CA medical office building valued at $69.3 million including the assumption of a $50.2 million mortgage loan with a fixed interest rate of 5.8% expiring in 2017 and the issuance of 121,489 OP units; the remaining 55.05% interest in two San Bernardino, CA assets that we did not already own with a total value of $17.4 million including the assumption of an $11.2 million mortgage loan with a variable interest rate currently at 3.0% expiring in July 2010; and a 71% interest in a joint venture which owns a medical office building in Pasadena, CA for $13.5 million. Additionally, we committed to loan the Pasadena, CA joint venture $59.5 million of which we have funded $52.8 million.

We have also signed the amended and restated pipeline agreement whereby Pacific Medical Buildings will be responsible for development and NHP will be responsible for project financing for approved development projects. Other modifications to the development agreement provide NHP with improved terms, including preferred returns, a reduced promote interest to PMB and pricing determined at the time of acquisition rather than at the pre-development stage.

Other Investments

We invested approximately $3.7 million in revenue producing capital expenditures at a blended yield of 8.6% on our existing triple-net portfolio and $80.1 million in an 8.25% loan secured by 26 medical office buildings located in seven states.

FIRST QUARTER 2010 FINANCING TRANSACTIONS

During the first quarter of 2010, we issued and sold 1.3 million shares of our common stock through our at-the-market equity offering program at an average price of $35.58 per share, resulting in net proceeds of approximately $44.7 million. From April 1, 2010 to May 6, 2010, we issued and sold 1.6 million shares of our common stock through our at-the-market equity offering program at an average price of $35.08 per share, resulting in net proceeds of approximately $55.2 million.

In the fourth quarter of 2009, we called for redemption our Series B convertible preferred stock. During the first quarter of 2010, shareholders of our Series B convertible preferred stock converted 512,727 shares of Series B preferred stock into 2.3 million shares of our common stock, and we redeemed the remaining 917 shares of our Series B convertible preferred stock.

2010 GUIDANCE

As a result of closed acquisitions and common shares issued through our release date of May 6, 2010, we are increasing by $0.08 per share the high end of the range from $2.09 per share to $2.17 per share and by $0.09 per share the low end of the range from $2.05 per share to $2.14 per share for our full-year 2010 adjusted diluted FFO guidance. We are also increasing by $0.08 per share the high end of the range from $2.05 per share to $2.13 per share and by $0.09 per share the low end of the range from $2.01 per share to $2.10 per share for our full-year 2010 adjusted diluted FAD guidance. Our guidance includes shares issued through our at-the-market equity offering program and closed acquisitions through May 6, 2010 and excludes any other acquisitions, investments, impairments or capital transactions that may occur in the remainder of 2010.

CONFERENCE CALL INFORMATION

We have scheduled a conference call and webcast on Friday, May 7, 2010 at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time) to discuss these results. The conference call is accessible by dialing 800-299-7098 and referencing conference ID number 32150685 or by logging on to our website at http://www.nhp-reit.com. The international dial-in number is 617-801-9715. The earnings release and any additional financial information that may be discussed on the conference call and webcast will also be available at the same location on our website. A digitized replay of the conference call will be available from 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time) that day until 9:00 p.m. Pacific Time (Midnight Eastern Time) on June 7, 2010. Callers can access the replay by dialing 888-286-8010 or 617-801-6888 and entering conference ID number 46033547. Webcast replays will also be available on our website for at least 12 months following the conference call. Our supplemental information package for the quarter ended March 31, 2010 is available on our website, free of charge, at http://www.nhp-reit.com by selecting "Investor Relations" followed by "Financial Information" and is included in our Current Report on Form 8-K filed May 6, 2010 with the SEC also containing this release. Shareholders may receive free of charge a complete set of our audited financial statements upon request.

ABOUT NATIONWIDE HEALTH PROPERTIES, INC.

Nationwide Health Properties, Inc. is a real estate investment trust (REIT) that invests primarily in healthcare real estate in the United States. As of March 31, 2010, the Company's portfolio of properties, including mortgage loans and properties owned by unconsolidated joint ventures, totaled 606 properties among the following segments: 279 senior housing facilities, 197 skilled nursing facilities, 112 medical office buildings, 11 continuing care retirement communities and 7 specialty hospitals. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.

FORWARD LOOKING STATEMENTS

Certain information contained in this release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as "may," "will," "anticipates," "expects," "believes," "intends," "should" or comparable terms or the negative thereof. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. Risks and uncertainties associated with our business include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent, interest or loan principal amounts by our tenants; our reliance on two tenants for a significant percentage of our revenue; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; maintaining compliance with our debt covenants; access to the capital markets and the cost and availability of capital; the effect of healthcare reform legislation or government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; risks associated with acquisitions, including our ability to identify and complete favorable transactions, delays or failures in obtaining third party consents or approvals, the failure to achieve perceived benefits, unexpected costs or liabilities and potential litigation; the ability of our tenants to pay contractual rent and/or interest escalations in future periods; the ability of our tenants to obtain and maintain adequate liability and other insurance; our ability to attract new tenants for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our senior notes; changes in or inadvertent violations of tax laws and regulations and other factors that can affect our status as a real estate investment trust; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission, especially the "Risk Factors" sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. Forward-looking information is provided by us pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. We disclaim any intent or obligation to update these forward-looking statements.

***Financial Tables to Follow***





SELECTED FINANCIAL DATA ($ in thousands, except per share amounts)

SOURCE Nationwide Health Properties, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Interleukin Genetics, Inc. Announces Conference Ca...
S
Centene Corporation to Acquire Arkansas Health Pla...